Home » Making Sense of FDA's Risk-Based Initiative

Making Sense of FDA's Risk-Based Initiative

Overview:

Here's a no-nonsense three-page overview of FDA's 21st Century cGMP guidelines, written by attorney Patricia J. Kaeding, formerly of FDA's Office of Chief Counsel.

File Size: 953 KB

Find more white papers on Quality Assurance Control

View all white papers »

More content on this topic: